ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-OR075

Consequences of Declining a Public Health Service Increased Risk (PHS-IR) Donor Kidney

Session Information

Category: Transplantation

  • 1702 Transplantation: Clinical and Translational

Authors

  • Fernandez, Hilda E., NYP-CUMC, NYC, New York, United States
  • Chiles, Mariana C., NYP-CUMC, NYC, New York, United States
  • Pereira, Marcus, NYP-CUMC, NYC, New York, United States
  • Husain, Syed Ali, NYP-CUMC, NYC, New York, United States
  • Mohan, Sumit, NYP-CUMC, NYC, New York, United States
Background

The risk of disease transmission from PHS-IR kidney donors is extremely low but the perception increased risk by patients may adversely impact their willingness to accept these organs.

Methods

We performed a retrospective, single-center study of all PHS-IR kidney offers made to patients at Columbia University Medical Center (CUMC) from 6/2004 to 5/2015 to 1) identify who was likely to accept these organs and 2) assess the potential consequences of declining such offer.

Results

Among 2423 candidates who received a PHS-IR kidney offer, 358 accepted and 2065 declined. On multivariate analysis, higher estimated post-transplant survival (EPTS) score (OR=1.005, p=0.025), male sex (OR=1.345, p=0.035), and higher educational achievement (OR=0.693, p=0.025) appear to influence organ offer acceptance. Among those who declined, 57.5% subsequently received a non-PHS-IR transplant while 16.5% remained on the waitlist. Acceptance of a PHS-IR offer was associated with a lower mortality (3.63% vs 11.6%; adjusted HR 0.467, p=0.0008) and PHS-IR allografts were associated with lower death censored allograft failure rates (HR = 0.677, p=0.041).

Conclusion

Declining a PHS-IR kidney offer appears to be associated with a survival disadvantage at our center. This underscores the importance of patient education regarding the risks and benefits of PHS-IR organs. Efforts must be made to increase acceptance of PHS-IR organs in order to improve outcomes for those on the waitlist.

Funding

  • NIDDK Support